platelet
Enable an agent to recognise a blood platelet, assess its observed condition and functional potential, and determine which analyses or handling actions are justified by the available evidence.
Research draft, second pass
A second pass drafted this model: the structure a model of this thing needs, and what is known about it in the world. The line under this one says how the second half was obtained - researched against sources, or recalled without web access, in which case nothing here was read anywhere and every claim is a lead to verify. Unreviewed either way.
recalled by Codex without web access - no source was read
Researched by: Codex
Purpose and description
Enable an agent to recognise a blood platelet, assess its observed condition and functional potential, and determine which analyses or handling actions are justified by the available evidence.
A platelet is a small, anucleate blood cell fragment derived from a megakaryocyte in mammals that contributes to haemostasis by adhering to damaged vessels, aggregating with other platelets and supporting coagulation.
It can be Identify candidate platelets using morphology and corroborating assay evidence.; Count and characterise a platelet population while flagging clumps and other measurement interference.; Compare baseline and stimulated platelet responses under a documented assay protocol.; Record adhesion, secretion and aggregation as distinct but related behaviours.; Assess whether specimen history supports the intended platelet analysis.; Flag uncertain identity or compromised specimens for additional examination..
Distinguishing features
A mammalian blood platelet lacks a nucleus but retains a membrane, cytoplasm, organelles and specialised granules; absence of a nucleus alone does not distinguish it from an erythrocyte.
Platelet identity can be supported by morphology and a context-appropriate marker panel such as CD41, CD61 and CD42b; no single marker should establish identity independently.
A platelet is distinguished from a megakaryocyte by its status as a released cellular fragment rather than a large nucleated precursor.
A platelet must be distinguished from platelet-derived extracellular vesicles using size, structure and the identification method together.
Blood specimen context and cellular organisation distinguish a blood platelet from a flat particle described geometrically as a platelet.
Scope
+ Platelet identity, mammalian species context and megakaryocyte origin
+ Membrane, granules, cytoskeleton and structural integrity
+ Resting, activated, aggregated and damaged states
+ Adhesion, secretion and participation in haemostasis
+ Platelet-specific measurements and specimen handling effects
- Platelet-shaped mineral particles and engineered material flakes
- Megakaryocyte development and regulation of platelet production as complete processes
- Nucleated thrombocytes of non-mammalian vertebrates
- Whole coagulation pathways and complete thrombus models
- Diagnosis and treatment of platelet disorders
- Platelet transfusion products, prescribing and release requirements
Characteristics
- Species and biological context
- Species; circulating blood, collected specimen or experimental preparation Determines whether the mammalian platelet definition and the selected measurement methods apply.
- Identity evidence
- Morphology; marker panel; analyser classification; supporting method and confidence Prevents cellular debris, vesicles or other blood components from being classified as platelets without adequate evidence.
- Cellular dimensions
- Diameter in µm or volume in fL, with method and specimen conditions Supports identification and interpretation of size variation without treating method-dependent measurements as interchangeable.
- Platelet concentration in a specimen
- 10^9/L, with specimen identifier, method and interference flags Describes the surrounding platelet population rather than an intrinsic property of one platelet.
- Activation evidence
- Baseline, stimulated, activation detected or indeterminate; assay-specific indicators Separates observed activation from assumptions based on collection conditions or appearance.
- Granule secretion response
- Assay-specific release quantity or signal, with agonist, dose and timing Records a functional response distinct from platelet count and aggregation.
- Adhesion and aggregation response
- Assay-specific endpoint with substrate, agonist, flow conditions and elapsed time Makes functional results interpretable within the conditions that produced them.
- Membrane and structural integrity
- Preserved, altered, disrupted or indeterminate, with observed indicators Helps distinguish functional activation from deterioration or physical damage.
- Collection and processing history
- Linked specimen record containing anticoagulant, collection time, temperature and processing events Handling can alter platelet morphology, activation and measured function.
Also called
Where this came from
wikidata · CC0 1.0
Also registered as vr.tr.platelet
Drafted structure
Bundle to layer to finding to question, as the second pass will find it: 5 bundles · 9 layers · 15 findings · 25 questions.
Platelet identity and origin Establishes the biological sense, species context and evidence for platelet identity.
The registry's material domain does not make a platelet a pure chemical substance, and the name also has non-biological uses.
Biological sense and boundary
Separates mammalian blood platelets from similarly named particles and neighbouring cell types.
Blood platelet identification
Record species, specimen context and the evidence used to identify an anucleate platelet rather than another particle.
- Does platelet refer here to a mammalian blood component or to a particle with a plate-like shape? definition
- What observations distinguish this candidate from an erythrocyte fragment, extracellular vesicle or nucleated thrombocyte? boundary
Megakaryocyte origin
Records the relationship to the platelet-producing precursor without modelling the entire production pathway.
Origin and preparation evidence
Distinguish circulating platelets from experimentally generated preparations, and separate demonstrated provenance from inferred origin.
- Was this platelet observed in circulating blood, isolated from a collected specimen or generated in an experimental system? provenance
- What evidence supports its megakaryocyte origin, and which parts of that origin are inferred? provenance
Platelet structure and integrity Captures platelet morphology, cellular machinery and evidence of damage.
An anucleate platelet remains a complex cellular fragment whose structure affects recognition and function.
Morphology and size
Describes dimensions and shape in relation to observation conditions.
Observed platelet morphology
Record size, shape and extensions alongside preparation conditions so observed changes are not automatically treated as intrinsic abnormalities.
- What size and shape were observed, by which method and at what time after collection? measurement
- Could spreading, shape change or apparent fragmentation reflect activation or specimen preparation? boundary
Membrane and granules
Records evidence about the platelet membrane, granules and retained cellular structures.
Structural capacity and damage
Document membrane integrity and granule observations while distinguishing missing structures, released contents and inadequate detection.
- What evidence establishes membrane integrity and the presence or condition of alpha and dense granules? measurement
- Can reduced granule signal be distinguished from secretion, structural deficiency or a limitation of the method? boundary
Platelet activation and haemostasis Records the responses through which platelets adhere, secrete, aggregate and support coagulation.
Platelet identity and count do not establish functional behaviour; each response needs its own evidence and conditions.
Activation and secretion
Separates baseline condition, applied stimuli and measured responses.
Stimulus-linked response
Link activation and secretion observations to agonist, dose, timing and controls rather than assigning a universal activation score.
- Which stimulus, concentration and exposure time preceded the measured activation or secretion response? measurement
- What baseline and controls distinguish a stimulus response from activation introduced during handling? measurement
Adhesion, aggregation and coagulation support
Distinguishes attachment to surfaces, platelet-to-platelet association and procoagulant surface activity.
Distinct haemostatic functions
Record the specific function demonstrated, including relevant substrate, receptor evidence and flow conditions, without equating one assay with total haemostatic competence.
- Does the observation demonstrate surface adhesion, platelet aggregation or procoagulant membrane activity? definition
- Which substrate, flow conditions and assay endpoint support that interpretation? measurement
- What additional functional evidence is needed before using this result for the intended assessment? action
Platelet specimen and observation quality Connects platelet observations to collection history, population context and analytical limitations.
Clumping and handling effects can change apparent platelet count and function without establishing an underlying biological disorder.
Collection and handling effects
Captures specimen conditions that may alter platelets before analysis.
Fitness for platelet analysis
Assess the collected specimen against the requirements of the intended assay using documented anticoagulant, time, temperature and processing history.
- Which anticoagulant, elapsed times, temperatures and processing steps apply to this specimen? provenance
- Does the documented history meet the intended assay's acceptance criteria, or is recollection or qualification required? action
Counting and population context
Places specimen-level measurements alongside interference evidence and appropriate comparison context.
Interpretable platelet population measurements
Keep platelet concentration and size-distribution summaries attached to the specimen, with flags for clumps, giant platelets and classification interference.
- What platelet concentration and size-distribution results were obtained, using which instrument or method? measurement
- Do clumps, unusually large platelets or non-platelet particles compromise the reported result? boundary
- Which validated review or repeat-measurement procedure applies when interference is detected? action
Evidence and external alignment What the world already says about this thing, gathered so the model can be checked against it.
A model that cannot be lined up against existing standards, identifiers and practice cannot be adopted by anyone who already uses them.
Reported evidence
Findings from the breadth pass, kept separate from the structural claims.
Check these first
Recalled without web access and unsourced; every item is a lead to verify.
- The entry has no recorded sense; this description assumes the biological meaning, although PHY.MAT could also accommodate a plate-shaped material particle.
- The listed kinds are descriptive categories of maturity and size, not a comprehensive subtype classification.
- Measurements are recalled typical human values; laboratory reference intervals and clinical interpretation require verification.
- Which of these check these first hold for the sense of platelet this model covers, and on what evidence? provenance
Kinds and varieties
Recalled without web access and unsourced; every item is a lead to verify.
- Immature or reticulated platelets
- Giant platelets
- Which of these kinds and varieties hold for the sense of platelet this model covers, and on what evidence? provenance
Real-world use
Recalled without web access and unsourced; every item is a lead to verify.
- Platelet counts help assess bleeding risk and investigate blood disorders.
- Platelet function testing investigates defects in adhesion, activation and aggregation.
- Donated platelet components are transfused to prevent or treat bleeding in selected clinical circumstances.
- Antiplatelet medicines target platelet activity to reduce arterial thrombosis.
- Which of these real-world use hold for the sense of platelet this model covers, and on what evidence? provenance
Typical measurements
Recalled without web access and unsourced; every item is a lead to verify.
- Adult human blood platelet count - 150-450 - 10^9/L
- Resting human platelet diameter - 2-3 - µm
- Human platelet circulating lifespan - 7-10 - days
- Which of these typical measurements hold for the sense of platelet this model covers, and on what evidence? provenance
Failure modes and hazards
Recalled without web access and unsourced; every item is a lead to verify.
- Low platelet numbers can impair haemostasis and increase bleeding risk.
- Platelet dysfunction can cause bleeding despite a normal platelet count.
- Inappropriate platelet activation contributes to arterial thrombosis.
- Markedly elevated platelet counts can accompany disorders associated with thrombosis or bleeding.
- Platelet clumping in a blood sample can produce a falsely low automated count.
- Which of these failure modes and hazards hold for the sense of platelet this model covers, and on what evidence? provenance
Regional variation
Recalled without web access and unsourced; every item is a lead to verify.
- Laboratories differ in platelet-count reference intervals and reporting units.
- Which of these regional variation hold for the sense of platelet this model covers, and on what evidence? provenance
Neighbouring kinds and how to tell them apart
Recalled without web access and unsourced; every item is a lead to verify.
- megakaryocyte - A megakaryocyte is a large, nucleated precursor cell that produces platelets.
- thrombocyte - In human usage this can mean platelet; in many non-mammalian vertebrates it denotes a nucleated haemostatic cell.
- platelet transfusion component - This is a prepared blood product containing many platelets and a suspending medium, rather than an individual platelet.
- materials-science platelet - This denotes a thin, plate-shaped particle or crystal rather than a blood component.
- Which of these neighbouring kinds and how to tell them apart hold for the sense of platelet this model covers, and on what evidence? provenance
What the second pass must settle
- Does the registry intend the blood-cell sense exclusively, and does an existing world model already own that concept?
- Which species must the model support, and what species-specific identity markers and assay interpretations require separate treatment?
- Which validated methods and reference contexts should govern platelet dimensions, population indices and functional measurements?
- What assay-specific evidence best distinguishes activation, deterioration and irreversible functional impairment?
- How much coverage of platelet immune and inflammatory interactions is needed beyond the haemostatic functions in this draft?